Clinical trial
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With…
NCT00002949 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00002949 |
|---|---|
| Title | Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis |
| Official title | Phase I Study of Concomitant Chemoradiotherapy With Vinorelbine and Paclitaxel in Patients With Advanced Pelvic Malignancies |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Cervical Cancer, Endometrial Cancer, Vaginal Cancer |
| Intervention type | Drug, Radiation |
| Interventions | paclitaxel, vinorelbine tartrate, radiation therapy |
| Enrollment | 33 |
| Start date | Jul 1, 1996 |
| Primary completion | Nov 1, 2000 |
| Completion | May 1, 2001 |
| First posted | Jun 16, 2004 |
| Last update posted | Sep 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: